Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$9.9M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 8 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 10 most recent Form 4 transactions.
| Open the original filing on SEC.gov |
| May 11 | ANIP | Ani Pharmaceuticals INC | SSELL | 55,000 | $77.57 | $4.3M | -13.6% | Open the original filing on SEC.gov |
| Mar 7 | ANIP | Ani Pharmaceuticals INC | FTAX | 17,060 | $74.04 | $1.3M | -4.0% | Open the original filing on SEC.gov |
| Feb 28 | ANIP | Ani Pharmaceuticals INC | FTAX | 12,217 | $73.90 | $902.8K | -2.8% | Open the original filing on SEC.gov |
| Feb 26 | ANIP | Ani Pharmaceuticals INC | AGRANT | 75,592 | $77.15 | $5.8M | +21.1% | Open the original filing on SEC.gov |
| Feb 14 | ANIP | Ani Pharmaceuticals INC | FTAX | 10,298 | $77.36 | $796.7K | -2.8% | Open the original filing on SEC.gov |
| Feb 12 | ANIP | Ani Pharmaceuticals INC | FTAX | 11,688 | $76.70 | $896.5K | -3.1% | Open the original filing on SEC.gov |
| Feb 11 | ANIP | Ani Pharmaceuticals INC | FTAX | 30,659 | $76.25 | $2.3M | -7.5% | Open the original filing on SEC.gov |
| Aug 12, 2025 | ANIP | Ani Pharmaceuticals INC | SSELL | 56,960 | $85.93 | $4.9M | -12.2% | Open the original filing on SEC.gov |